► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs<br /><br />David Crow reports from the FT US Healthcare and Life Sciences Conference in New York and asks pharmaceutical industry leaders whether a revolution in drug development could be hampered by a pricing backlash.<br /><br />► FT Business: http://bit.ly/1KUK08s<br /><br />► FT Global Economy: http://bit.ly/1J5mmqH<br /><br />► Budget 2015: Science relies on ringfencing: http://bit.ly/1KPrSQF<br /><br />Twitter https://twitter.com/ftvideo<br />Facebook https://www.facebook.com/financialtimes
